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A B S T R A C T
SOX2 variants have been identiﬁed in multiple patients with severe ocular anomalies and pituitary dysfunction,
in addition to various systemic features.
We investigated a 26-year-old female patient suﬀering from spastic paraparesis, hypoplasia of corpus cal-
losum, hypogonadotropic hypogonadism (HH) and intellectual disability, who was monitored for over 20 years,
allowing a detailed genotype-phenotype correlation along time. Whole exome sequencing on the patient and her
relatives identiﬁed a de novo SOX2 c.70del20 variant, which has been frequently reported in individuals with
SOX2-related anophthalmia. Importantly, our patient lacked major ocular phenotype but showed vaginal
agenesis, a feature never reported before. Although the involvement of male urogenital tract (cryptorchidism,
hypospadias, small penis), is a well known consequence of SOX2 variants, their eﬀect on the female genitalia has
never been properly addressed, even considering the paradoxical female excess of SOX2 cases in the literature.
Our ﬁndings emphasize the importance of testing for SOX2 variants in individuals with HH and genital
anomalies even though anophthalmia or microphthalmia are not observed. Moreover, our case strengthens the
role of SOX2 as a master regulator of female gonadal diﬀerentiation, as widely demonstrated for other SOX genes
related to 46, XX sex reversal, such as SOX3 and SOX9.
1. Introduction
SOX2 (OMIM 206900), a SOX1B-HMG box transcription factor in-
volved in early embryonic development with a critical role in eye,
forebrain, and hypothalamo-pituitary development, has been shown to
cause uni- and bilateral anophthalmia/microphthalmia (A/M) as well
as related disorders such as anophthalmia/esophageal-genital syn-
drome (AEG) or A/M and esophageal atresia (AMEA). In addition, SOX2
variants are associated with a wide range of extra-ocular manifesta-
tions: intrauterine growth restriction, postnatal growth retardation,
male hypogenitalism, hypogonadotropic hypogonadism (HH), hypo-
plasia of the corpus callosum, seizures, sensorineural hearing loss,
learning disability with speech delay, spastic diplegia/quadriplegia,
vertebral and dental anomalies (Fantes et al., 2003; Williamson et al.,
2006; Kelberman et al., 2008; Schneider et al., 2009; Numakura et al.,
2010; Chacon-Camacho et al., 20015). Aside from the infrequent mo-
saic cases, SOX2-positive cases without or only with minor eye phe-
notypes have been very rarely reported (Dennert et al., 2017).
Surprisingly, the intra-familial recurrence of deleterious SOX2 var-
iants is extremely infrequent. One explanation might be the occurrence
of genital tract abnormalities, plausibly related to reduced hypotha-
lamic-pituitary-gonadal axis hormones, or direct eﬀect of SOX2 hap-
loinsuﬃciency on the germ cells (Bakrania et al., 2007). In the mouse,
Sox2 is expressed in both male and female genitalia, and Sox2 hetero-
zygotes show male (but not female) reduced fertility, associated with
testicular abnormalities, diminished epididymal sperm count and mo-
tility (Avilion et al., 2003; Kelberman et al., 2006). In keeping with
these ﬁndings, SOX2 gonosomal mosaicism has been speciﬁcally de-
tected in the maternal samples (Faivre et al., 2006; Chassaing et al.,
2007; Schneider et al., 2008), suggesting that female gametogenesis is
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more tolerant of reduced SOX2 dosage than is spermatogenesis.
The involvement of male urogenital tract (cryptorchidism, hypos-
padias and micropenis) is a well known consequence of SOX2 variants
in humans (Fantes et al., 2003; Williamson et al., 2006; Kelberman
et al., 2006; Bakrania et al., 2007). Neverthless, their eﬀect on female
genitalia has never been properly addressed, although slight female
excess of SOX2 cases have been reported in the literature.
We studied a female patient with a SOX2 variant showing severe
genital anomalies, HH, spastic paraparesis, but no major ocular phe-
notype. We also provided an extensive revision of SOX2 patients car-
rying the recurrent c.70del20 variant with a speciﬁc focus on females
showing similarly rare genital anomalies.
1.1. Clinical report
The patient, a 26-year-old woman, was diagnosed with focal frontal
lobe epilepsy, spastic paraparesis and HH. She is second child of healthy
non-consanguineous parents, born after uneventful pregnancy. Family
history was unremarkable. At birth, weight was 3100 g and length
50 cm (50th centile). During infancy, speech development was normal,
while motor development was delayed. Hypertonia of the lower limbs
was diagnosed when she was 18 months and she is presently wheel-
chaired due to spastic gait. At the age of 20, she manifested stereotyped
episodes characterized by deviation of the eyes to the right followed by
sudden loss of consciousness with reduction of muscle tone and trau-
matic falls. Video-EEG revealed no abnormalities, while brain MRI
showed normal pituitary gland, corpus callosum hypoplasia and agen-
esis of the septum pellucidum (Fig. 1a). Neurological examination re-
vealed dysarthria, spastic-ataxic gait, spasticity of the upper and lower
limbs, and intellectual disability. At the last anthropometric evaluation,
weight was 57.6 Kg (50-75th centile), height 158 cm (25th centile),
head circumpherence 53 cm (25th centile), and arm span 166 cm (45th
centile). Physical examination detected various facial dysmorphisms:
high forehead and frontal hairline, wide sparse eyebrows, upslanted
palpebral ﬁssures, hypertelorism, wide nasal bridge, long ﬁltrum, thin
upper lip, large ears. Curiously, she had two supernumerary teeth with
persistence of deciduous central lower incisors. In addition, we ob-
served large chest, widely spaced nipples, thin lower limbs, cervical
lordosis, truncal obesity and ﬂat feet (Fig. 1b and c). Cardiological
evaluation (ECG, echo, Holter) did not identify anomalies. En-
docrinological and gynecological assessment revealed primary ame-
norrhea and oedematous labia, while abdominal ultrasounds detected
vaginal agenesis, hypoplastic uterus, and rudimentary gonads. At the
last hormonal evaluation, FSH was 0.2 mUI/ml, LH 0.1 mUI/ml, oes-
tradiol< 5.0 pg/ml, and testosterone 0.003 mg/ml; TSH, FT3, FT4 and
PRL were in the normal range. Ophthalmological examination revealed
hypermetropia of +1.25D sphere in the right eye and +0.75D sphere
in the left eye, and only minor ocular alterations: bilateral
Fig. 1. Clinical features of the 26-year-old proband.
(a) Brain MRI showing atrophy of corpus callosum. (b)
Patient's picture showing large chest, widely spaced
nipples, and thin lower limbs. (c) Facial dysmorphisms:
high forehead and frontal hairline, wide sparse eye-
brows, upslanted palpebral ﬁssures, hypertelorism,
squint, long ﬁltrum, thin upper lip.
Fig. 2. WES analysis in the family. (a) IGV
(Integrative Genomics View) visualization of the
SOX2 c.70del20 variant in the patient and re-
latives. The deletion's boundaries are delimited by
dashed blue lines. (b) Read depths (DP), Allelic
Depths (AD) and Mutation Allelic Fraction (Alt
Allele Freq) of the SOX2 variant. (c) Sanger se-
quencing validation, showing the heterozygous
frameshifting alteration. (For interpretation of the
references to colour in this ﬁgure legend, the
reader is referred to the Web version of this ar-
ticle.)
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microexotropia, mild corio-retinal dystrophy, and small vitreous retinal
retraction of the left eye.
Written informed consent was obtained in accordance with the in-
stitutional review boards of the University of Catania Ethics Committee.
2. Results
Karyotype revealed a normal 46, XX chromosomal pattern, while no
pathogenic CNVs were detected by the array-CGH. After an incon-
clusive preliminary screening of genes commonly associated with
spastic paraparesis (SPG4, SPG3A) and HH (KAL1, FGFR1, PROK2,
PROKR2), whole exome sequencing (WES) was performed on
DNA extracted from peripheral blood samples ot the proband
and her relatives. The analysis identiﬁed the recurrent
NM_003106.3(SOX2):c.70_89del20 frameshift variant (also known as
c.70del20) in the proband's DNA. This deletion predicts a p. Asn24fs*65
mutation upstream of the High Mobility Group (HMG) box and loss of
the majority of the protein, including the DNA-binding HMG and C-
terminal transactivation domains. The variant was not detected in both
parents and older healthy sister, indicating its de novo origin (Fig. 2).
The c.70del20 variant is unreported in ExAC, ESP, GoNL, 2000 Danes
WES (Diabetes Type 2 Study), and HGVD, while it is recorded in
dbSNP149 (#rs398123693), HGMD (#CD054424) and ClinVar
(#RCV000359617.1), and was previously described in 17 patients from
diﬀerent ethnic groups (Table 1). WES failed to identify variants in
other genes commonly associated with HH or hereditary spastic para-
plegia (Supplementary Tables 1 and 2).
3. Discussion
The c.70del20 is the most common SOX2 variant, accounting for up
to 20% of individuals with SOX2-related anophthalmia (Schneider
et al., 2009; Reis et al., 2010). It has been previously shown that it
generates a truncated protein lacking the DNA-binding HMG domain
and nuclear localization signals, thereby causing abnormal nuclear
transport of the mutant protein and inability to activate transcription of
diﬀerent DNA targets (e.g. the promoter of HESX1) required for the
normal development of forebrain, eyes, olfactory placodes and pituitary
gland (Kelberman et al., 2006). The ocular phenotype in patients car-
rying the c.70del20 variant usually include uni- or bilateral A/M, with
only very rare exceptions (Zenteno et al., 2006). Importantly, genital
anomalies (diagnosed in approximately 30% of cases) were exclusively
reported in male patients and included short penis, cryptorchidism,
foreskin adhesions and biﬁd scrotum. To our knowledge, this is the ﬁrst
report of a patient carrying the c.70del20 or any other SOX2 variant
with minimal expression of eye anomalies (corio-retinal dystrophy and
vitreous retraction) but vaginal agenesis. Indeed, previous studies re-
ported SOX2 variants in four female patients (aged 12.3–28 years) in
which A/M and HH coexisted with small or absent ovaries and rudi-
mentary uterus, but without vaginal involvement (Kelberman et al.,
2006, 2008; Sato et al., 2007). Schneider et al. (2009) described vaginal
adhesions in a 2-year-old female with right anophthalmia, left micro-
phthalmia, coloboma, glaucoma, and cataract. Since vaginal adhesions
represent a common ﬁnding in prepubertal females, it cannot be un-
equivocally linked to the SOX2 variant (c.16G > T) identiﬁed in that
patient. Finally, a female patient reported in DECIPHER (#281790)
harbouring a 7.63Mb de novo heterozygous deletion including SOX2,
had anophthalmia, microcephaly and ambiguous genitalia. Although
the deleted region contains several other morbid genes, none of them is
associated with sexual development (as well as microcephaly and an-
ophthalmia) at the heterozygous state, suggesting SOX2 as major con-
tributor. Together with our observations, all these data deﬁnitely ex-
pand the phenotypic spectrum of SOX2 haploinsuﬃciency to sexual
development in XX subjects. Accordingly, immunocytochemistry stu-
dies in the ovary of adult mice found high levels of SOX2 protein in the
oocytes (Avilion et al., 2003), and Runck et al. (2014) demonstratedTa
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that Shh knockout mice lack Sox2 expression and show abnormal
cloacal morphogenesis, leading to improper septation of the urethra,
vagina and rectum. Altogether these ﬁndings are in line with the critical
role of human SOX genes during embryogenesis and, considering their
expression pattern, in the developing reproductive and central nervous
systems.
Curiously, a study on a cohort of 346 patients with Mayer-
Rokitansky-Küster-Hauser syndrome (MRKHS; OMIM 277000), the
second most common cause of primary amenorrhea characterized by
uterovaginal aplasia in karyotypically normal females, identiﬁed oph-
thalmologic defects in twelve of them (Rall et al., 2015). Although
MRKHS etiology is still mainly unknown, HNF1B, one of the candidate
genes, interacts with SOX9 (STRING database, version 10.5). In addi-
tion, LHX1, another promising candidate for the disease, is connected to
the Sonic hedgehog signalling pathway (SHH), which in turn is asso-
ciated with isolated microphthalmia with coloboma 5 (MCOPCB5;
OMIM 611638). Collectively, these ﬁndings provide more compelling
evidence of the crosstalk between pathways involved in eye and uter-
ovaginal development, although with some exceptions due to in-
complete penetrance and extreme phenotypic variability, as underlined
by our SOX2 case.
Our patient also showed spastic paraparesis, a clinical feature only
rarely documented in SOX2 patients (Fantes et al., 2003; Numakura
et al., 2010; Kelberman et al., 2006). Animal studies demonstrated that
Sox2 is expressed in the ventricular zone and plays a key role in spinal
cord regeneration (Muñoz et al., 2015), whose ineﬃcient activation
recapitulates paraplegia and quadriplegia conditions observed in hu-
mans. These observations suggest the potential beneﬁt of a SOX2 gene
therapy, which has been recently applied in retinal pigment epithelium
cells and proposed for the treatment of age-related macular degenera-
tion (Ezati et al., 2017), not only to revert the ocular manifestations of
SOX2 haploinsuﬃciency but also its detrimental neurological implica-
tions.
In conclusion, our case strengthens the extraordinary pleiotropic
eﬀects of SOX2 dysregulation, and conﬁrms that SOX2 targeted testing
is not exclusively recommended in the case of obvious A/M. We spec-
ulate that female genital anomalies might be underestimated, since
most of SOX2 female patients that are reported in the literature were
diagnosed in early childhood and did not undergo prolonged clinical
follow-up.
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